Based on this rationale, it is plausible to speculate that Nxn mutations induced by these DM models may be altering the status of FLII/NXN/MYD88 interaction which regulates downstream NF-κB activation (Figure 3 and Figure 4). The gene discussed is NXN; the disease is diabetes mellitus.